Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Women of all ages will get round-the-clock access to comprehensive treatment
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
Daffodils by Artemis is a premiere luxury birthing centre offering mother and child care services.
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
In a European work-sharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth
Subscribe To Our Newsletter & Stay Updated
